Note of clarification regarding data about the association between the interleukin-1β -31T>C polymorphism and breast cancer risk

Breast Cancer Res Treat. 2016 Feb;155(3):415-7. doi: 10.1007/s10549-016-3699-x. Epub 2016 Feb 5.

Authors

Yadong Wang^{1

2}, Yan Wang³, Li Li³

Affiliations

¹ Department of Toxicology, Henan Center for Disease Control and Prevention, No. 105 of South Nongye Road, Zhengzhou, 450016, China. wangyd76@163.com.
² Henan Collaborative Innovation Center of Molecular Diagnosis and Laboratory Medicine, Xinxiang Medical University, Xinxiang, 453003, China. wangyd76@163.com.
³ Department of Toxicology, Henan Center for Disease Control and Prevention, No. 105 of South Nongye Road, Zhengzhou, 450016, China.

PMID: 26847128
DOI: 10.1007/s10549-016-3699-x

No abstract available

Keywords: Breast cancer; IL-1β; Meta-analysis; Polymorphism; Risk.

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Breast Neoplasms / genetics*
Female
Humans
Interleukin-1beta / genetics*
Polymorphism, Single Nucleotide*

Substances

Interleukin-1beta